Shares of Acorda Therapeutics (NASDAQ:ACOR) rose over 30% today after the company's lawyers made oral arguments in front of a panel at the U.S. Court of Appeals for the Federal Circuit late Thursday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,